Clinical Studies
Vacuum therapy clinical evidence
Vacuum erection device therapy has a place in conservative Peyronie's care, but the evidence is intentionally framed more cautiously than the traction pages.
Vacuum therapy is supportive, not definitive, for structural Peyronie's outcomes. The current source set is thinner than the RestoreX evidence base, with smaller studies, mixed designs, and weaker durability data. That doesn't make it irrelevant; it shapes how confidently the site can describe what to expect.
Where VED earns more confident language is in erection quality and penile rehabilitation. For curvature, length, and long-term durability, the wording stays measured on purpose.
How the evidence rates outcome by outcome
Erectile rehabilitation: moderate
Supported by observational and small trial data. Reasonable basis for discussion, especially when erectile function is part of the problem.
Curvature improvement: limited
The evidence base is smaller and less definitive than the traction source set. Claims are kept cautious for that reason.
Length preservation: limited
Some supportive signal in the literature; clinical weight stays cautious because the studies are small.
Long-term durability: emerging
Insufficient data in the current source set to make confident long-term claims.
Where VED language stays confident
- Erection quality and rehabilitation goals.
- Non-invasive option that fits early conservative care.
- Adjunct role alongside other conservative therapies.
- Patient-led use without injections or surgery.
Where VED language stays measured
- Curvature reduction as a primary outcome.
- Length recovery claims.
- Long-term structural durability.
- Direct comparison against device-specific trial evidence.
VED therapy can still be worth exploring, especially when erectile function is part of the problem, but expectations should track what the evidence actually supports.
Use this evidence to frame the VED conversation
Stay informed
Get practical Peyronie's updates
Receive new guides, treatment explainers, and evidence-based updates by email. Unsubscribe at any time.